Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?

Background: The effects of the risk factors of ischemic heart disease (IHD) and stroke on the occurrence of these diseases differ between different populations. Objectives: To study the difference in the effects of different cardiovascular (CVD) risk factors on the incidence of IHD and stroke in an...

Full description

Bibliographic Details
Main Authors: Samaneh Aalami Harandi, Nizal Sarrafzadegan, Masoumeh Sadeghi, Mohammad Talaei, Mino Dianatkhah, Shahram Oveisgharan, Ali Pourmoghaddas, Asma Salehi, Zohre Sedighifard
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Research in Cardiovascular Medicine
Subjects:
Online Access:http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2016;volume=5;issue=1;spage=9;epage=9;aulast=Harandi;type=0
id doaj-c0fcdb4e49b44814980dc2f48a186929
record_format Article
spelling doaj-c0fcdb4e49b44814980dc2f48a1869292020-11-25T00:23:39ZengWolters Kluwer Medknow PublicationsResearch in Cardiovascular Medicine2251-95722251-95802016-01-01519910.5812/cardiovascmed.30619Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?Samaneh Aalami HarandiNizal SarrafzadeganMasoumeh SadeghiMohammad TalaeiMino DianatkhahShahram OveisgharanAli PourmoghaddasAsma SalehiZohre SedighifardBackground: The effects of the risk factors of ischemic heart disease (IHD) and stroke on the occurrence of these diseases differ between different populations. Objectives: To study the difference in the effects of different cardiovascular (CVD) risk factors on the incidence of IHD and stroke in an Iranian adult population. Patients and Methods: The Isfahan Cohort Study (ICS) is a longitudinal study that followed up 6323 subjects older than 35 years with no history of CVD since 2001. Of the original sample, only 5431 participants were contacted and followed up until 2011. The end points were the occurrence of IHD (defined as fatal and non-fatal myocardial infarction, unstable angina, and sudden cardiac death) and stroke. After 10 years of follow-up, 564 new cases of IHD and 141 new cases of stroke were detected. The relative risks (RRs) of cardiometabolic risk factors such as hypertension, diabetes, hypercholesterolemia, hypertriglyceridemia, high low-density lipoprotein cholesterol (LDL-C) level, low high-density lipoprotein cholesterol (HDL-C) level, current smoking, obesity, high waist-to-hip ratio, family history of CVD, and metabolic syndrome were compared between IHD and stroke patients. The ratio of relative risks (RRR) was calculated for comparing two RRs and estimated adjusted RRR was calculated by using generalized linear regression with a log link and binomial distribution. Results: The RRs of the occurrence of IHD and stroke in diabetic patients were 1.94 and 3.26, respectively, and the difference was statistically different (P = 0.016). The RR of high LDL-C was significantly higher for IHD than for stroke (P = 0.045), while all the other risk factors showed similar RRs for IHD and stroke, with no significant difference in their RRR, including hypertension. Diabetes and hypertension had the highest RRs for IHD, followed by diabetes, metabolic syndrome, and hypertension for stroke. Conclusions: The effect of diabetes mellitus on stroke was more significant than on IHD, and the effect of high LDL-C level was more significant on IHD than on stroke, other risk factors, including hypertension, have similar RRs for IHD and stroke. Health care professionals need more training regarding the RRs of these risk factors in the Iranian society, and health decision makers should consider it in their future policies.http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2016;volume=5;issue=1;spage=9;epage=9;aulast=Harandi;type=0Cardiovascular Diseases; Risk Factors; Stroke; Myocardial Ischemia; Cohort Studies
collection DOAJ
language English
format Article
sources DOAJ
author Samaneh Aalami Harandi
Nizal Sarrafzadegan
Masoumeh Sadeghi
Mohammad Talaei
Mino Dianatkhah
Shahram Oveisgharan
Ali Pourmoghaddas
Asma Salehi
Zohre Sedighifard
spellingShingle Samaneh Aalami Harandi
Nizal Sarrafzadegan
Masoumeh Sadeghi
Mohammad Talaei
Mino Dianatkhah
Shahram Oveisgharan
Ali Pourmoghaddas
Asma Salehi
Zohre Sedighifard
Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
Research in Cardiovascular Medicine
Cardiovascular Diseases; Risk Factors; Stroke; Myocardial Ischemia; Cohort Studies
author_facet Samaneh Aalami Harandi
Nizal Sarrafzadegan
Masoumeh Sadeghi
Mohammad Talaei
Mino Dianatkhah
Shahram Oveisgharan
Ali Pourmoghaddas
Asma Salehi
Zohre Sedighifard
author_sort Samaneh Aalami Harandi
title Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
title_short Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
title_full Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
title_fullStr Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
title_full_unstemmed Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
title_sort do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?
publisher Wolters Kluwer Medknow Publications
series Research in Cardiovascular Medicine
issn 2251-9572
2251-9580
publishDate 2016-01-01
description Background: The effects of the risk factors of ischemic heart disease (IHD) and stroke on the occurrence of these diseases differ between different populations. Objectives: To study the difference in the effects of different cardiovascular (CVD) risk factors on the incidence of IHD and stroke in an Iranian adult population. Patients and Methods: The Isfahan Cohort Study (ICS) is a longitudinal study that followed up 6323 subjects older than 35 years with no history of CVD since 2001. Of the original sample, only 5431 participants were contacted and followed up until 2011. The end points were the occurrence of IHD (defined as fatal and non-fatal myocardial infarction, unstable angina, and sudden cardiac death) and stroke. After 10 years of follow-up, 564 new cases of IHD and 141 new cases of stroke were detected. The relative risks (RRs) of cardiometabolic risk factors such as hypertension, diabetes, hypercholesterolemia, hypertriglyceridemia, high low-density lipoprotein cholesterol (LDL-C) level, low high-density lipoprotein cholesterol (HDL-C) level, current smoking, obesity, high waist-to-hip ratio, family history of CVD, and metabolic syndrome were compared between IHD and stroke patients. The ratio of relative risks (RRR) was calculated for comparing two RRs and estimated adjusted RRR was calculated by using generalized linear regression with a log link and binomial distribution. Results: The RRs of the occurrence of IHD and stroke in diabetic patients were 1.94 and 3.26, respectively, and the difference was statistically different (P = 0.016). The RR of high LDL-C was significantly higher for IHD than for stroke (P = 0.045), while all the other risk factors showed similar RRs for IHD and stroke, with no significant difference in their RRR, including hypertension. Diabetes and hypertension had the highest RRs for IHD, followed by diabetes, metabolic syndrome, and hypertension for stroke. Conclusions: The effect of diabetes mellitus on stroke was more significant than on IHD, and the effect of high LDL-C level was more significant on IHD than on stroke, other risk factors, including hypertension, have similar RRs for IHD and stroke. Health care professionals need more training regarding the RRs of these risk factors in the Iranian society, and health decision makers should consider it in their future policies.
topic Cardiovascular Diseases; Risk Factors; Stroke; Myocardial Ischemia; Cohort Studies
url http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2016;volume=5;issue=1;spage=9;epage=9;aulast=Harandi;type=0
work_keys_str_mv AT samanehaalamiharandi docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT nizalsarrafzadegan docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT masoumehsadeghi docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT mohammadtalaei docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT minodianatkhah docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT shahramoveisgharan docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT alipourmoghaddas docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT asmasalehi docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
AT zohresedighifard docardiometabolicriskfactorsrelativerisksdifferfortheoccurrenceofischemicheartdiseaseandstroke
_version_ 1725355768233852928